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Background: It can be useful to know the transgene insertion site in transgenic mice for a variety of reasons,
but determining the insertion site generally is a time consuming, expensive, and laborious task.
Methods: A simple method is presented to determine transgene insertion sites that combines the enrichment of a
sequencing library by polymerase chain reaction (PCR) for sequences containing the transgene, followed by
next-generation sequencing of the enriched library. This method was applied to determine the site of integration
of the thyroid peroxidase promoter–Cre recombinase mouse transgene that is commonly used to create thyroid-
specific gene deletions.
Results: The insertion site was found to be between bp 12,372,316 and 12,372,324 on mouse chromosome 9,
with the nearest characterized genes being Cntn5 and Jrkl,*1.5 and 0.9 Mbp from the transgene, respectively.
One advantage of knowing a transgene insertion site is that it facilitates distinguishing hemizygous from
homozygous transgenic mice. Although this can be accomplished by real-time quantitative PCR, the expected
Ct difference is only one cycle, which is challenging to assess accurately. Therefore, the transgene insertion site
information was used to develop a 3-primer qualitative PCR assay that readily distinguishes wild type,
hemizygous, and homozygous TPO-Cre mice based upon size differences of the wild type and transgenic allele
PCR products.
Conclusions: Identification of the genomic insertion site of the thyroid peroxidase promoter–Cre mouse
transgene should facilitate the use of these mice in studies of thyroid biology.
Introduction
Transgenic mice are widely used in biomedical re-search and are invaluable resources for the study of
normal physiology and disease. In general, transgenes insert
at approximately random locations within the mouse ge-
nome. This has important implications. For example, the
expression of nearby genes may be disrupted, or nearby
sequences may influence the expression of the transgene.
Therefore, knowing the insertion site of a transgene within
the mouse genome can be important. There also are practi-
cal advantages in knowing a transgene insertion site. For
example, this should facilitate the development of qualita-
tive polymerase chain reaction (PCR) assays to distinguish
hemizygous from homozygous transgenic mice. Simply
knowing the chromosome on which a transgene is located
also can be of value, for example if the investigator wishes to
breed transgenic mice with other genetically modified mice.
Nevertheless, transgene insertion sites have only rarely been
determined because doing so has been laborious, time con-
suming, and expensive.
The authors’ laboratory studies a form of thyroid cancer
caused by a gene fusion between PAX8 and PPARG, which
results in production of an oncogenic PAX8–PPARG fusion
protein, PPFP (1). The authors have created a mouse model
of this disease in which expression of a transgenic PPFP
cDNA and deletion of endogenous Pten (thereby activating
Akt) are dependent on expression of Cre recombinase (2).
Mice that contain the Cre-dependent PPFP transgene and
that have homozygous floxed Pten alleles are bred to mice
which are homozygous both for floxed Pten and for a trans-
gene in which the thyroid-specific thyroid peroxidase (TPO)
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promoter drives expression of Cre (3). Mice that are homo-
zygous for TPO-Cre are preferred over hemizygous mice
because it allows the breeding scheme to be much more ef-
ficient. However, it is difficult to distinguish homozygous
from hemizygous transgenic mice unambiguously by quan-
titative real-time PCR, since the expected difference in Ct
values is only one cycle. Identification of the transgene in-
sertion site would facilitate the development of a qualitative
PCR assay to distinguish homozygotes from hemizygotes.
For these reasons, a combination of PCR enrichment of a
sequencing library with next-generation sequencing of the
PCR products was used to circumvent these limitations and to
identify the genomic insertion site of the TPO-Cre transgene.
This approach should facilitate the determination of any
transgene insertion site.
Materials and Methods
Transgenic TPO-Cre mice
All animal husbandry procedures were approved by the
Institutional Animal Care and Use Committee of the Uni-
versity of Michigan. Transgenic mice in which the TPO
promoter drives the expression of Cre recombinase (TPO-
Cre) have been described (3). This transgene contains the
human TPO promoter, Cre recombinase. and mouse Mt1
polyadenylation sequences, flanked by dual chicken HS4
insulators.
Generation of DNA sequencing library
and next-generation sequencing
Liver DNA from a hemizygous or homozygous TPO-Cre
mouse was prepared using a Promega Wizard Genomic DNA
Purification Kit. A DNA sequencing library was prepared in
the University of Michigan DNA Sequencing Core from that
genomic DNA. Briefly, the DNA was sheared using the
Covaris S2 system, and fragments of approximately 550 bp
were isolated by agarose gel electrophoresis, excision, and
purification. The purified DNA was converted to a sequencer-
ready library using the NEB-Next DNA Sample Prep Kit
(New England Biolabs), according to the manufacturer’s
recommended protocols. One lL of this library was am-
plified by 35 cycles of PCR using Promega GoTaq G2
Polymerase and cycling conditions of 95C · 3 min; then
35 cycles of 95C · 30 sec, 60C · 30 sec, and 72C · 1 min,
and then 72C · 5 min. One PCR primer is denoted LP2
and is identical to Illumina’s ‘‘TruSeq PCR Primer 2’’ (see
Table 1), and the other primer is denoted TG1 and is directed
at sequences within the 5¢ end of the transgene. Because the
LP2 primer is only present on one end of each library frag-
ment, it is unable to initiate exponential amplification by
itself. Only when the gene-specific (TG1, in this case) primer
also is present will exponential amplification be possible. All
primer sequences are provided in Table 1, and a schematic
representation of the PCR strategies is shown in Figure 1.
The product of this PCR was diluted 1000-fold in water,
and 1 lL was subjected to a second round of PCR that utilized
LP2 with a new transgene-specific primer, TG2, that was
nested relative to TG1 (i.e., closer to the 5¢ end of the
transgene). As a specificity control, the transgene-specific
primer was replaced by primer TG3, located farther away
from the 5¢ end of the transgene and therefore expected to
yield no product. These reaction products were subjected to
agarose gel electrophoresis to confirm successful amplifica-
tion of DNA only from the appropriately nested reaction, and
that material was then subjected to next generation se-
quencing using a Pacific Biosciences RS II sequencing sys-
tem. Briefly, libraries were created using Pacific Biosciences
recommended protocols for small fragments, and sequenced
on the RS II according to the manufacturer’s recommended
protocols for diffusion loading, using the P4/C2 chemistry
with circular consensus data analysis. The resulting FASTA
files were analyzed manually, via a simple text search to
identify sequence reads containing the TG2 primer sequence.
Sequences found adjacent to TG2 were then manually sub-
mitted to NCBI BLAST to identify any putative mouse
chromosomal sequence.
As described in the Results, this yielded a tentative iden-
tification of the integration site of the 5¢ end of the transgene
Table 1. Polymerase Chain Reaction Primer
Sequences Used in the Determination
of the Transgene Insertion Site
Primer
name Primer sequence
LP2 CAA GCA GAA GAC GGC ATA CGA GAT
LP2a CAA GCA GAA GAC GGC ATA CG
LP2b CAG AAG ACG GCA TAC GAG A
TG1 CTG CCG GCT CGG GGA T
TG2 TAG CGG GGG AGG GAC GT AAT
TG3 CGT GCC CGG GCT GTC
9.1 TCA TTG GTG GGC TTT GAG TCT
9.2 TGC AAT ACA ATT AGT GAG AAT GAG A
9.3 TCA TTG TAG AAT CAA TGA CCT AAA C
9.4 TGC CAC ATA CAC TAA CTG TGA GA
FIG. 1. Schematic representation of polymerase chain
reaction (PCR) primers used in determination of the trans-
gene insertion site. Hypothetical sequencing library mole-
cules are shown that contain the library adapter and a
genomic fragment that includes either the 5¢ or 3¢ junction of
the transgene with the mouse genomic DNA. The positions
of PCR primers are shown. A similar schematic is shown to
illustrate primers used to PCR the 5¢ insertion site from
genomic DNA. The schematics are not drawn to scale.
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in mouse chromosome 9. A PCR primer pair was then created
to confirm this, with one primer being in the mouse genome
(primer 9.1) and the other in the transgene (TG1); the product
was subjected to conventional Sanger sequencing. Similar
approaches were used to identify the 3¢ integration site, as
presented in the Results.
Results
Identification of the TPO-Cre transgene
genomic insertion site
Only a tiny fraction of the DNA molecules in a sequencing
library will contain the junction between the host chromo-
some and the transgene. To enrich for these molecules, nested
PCR was utilized. In the first reaction, one primer (LP2) was a
subsequence of the adapter used in construction of the library,
and the other primer was directed at transgene sequences near
the 5¢ end of the transgene (primer TG1; Fig. 1). Amplifica-
tion of the sequencing library with these primers is expected
to have only modest specificity, since primer LP2 will anneal
to all DNA molecules in the library. Therefore, the products
of this PCR were subjected to a second round of PCR that
used LP2 with transgene-specific primer TG2 that was nested
relative to TG1 (i.e., closer to the 5¢ end of the transgene). As
shown in Figure 2, this resulted in a smear of products, which
is the expected result, since the distance between TG2 and the
5¢ end of each library molecule will be variable. As a speci-
ficity control, primer TG2 was replaced with TG3, which is
located external to TG1, and hence should not be able to
amplify true transgene products from the first round of PCR.
This yielded very little product, as expected (Fig. 2).
The products of the nested PCR with primers LP2 and TG2
were subjected to sequencing using a Pacific Biosciences RS
II sequencing system, and sequencing reads were found (by
manual search) that contained both transgene-specific primer
and mouse chromosomal sequences. This indicated that the
transgene is on chromosome 9, oriented on the reverse strand,
with chromosome 9 bp 12,372,324 adjacent to the 5¢ end of
the transgene (Fig. 3). To confirm this insertion site, genomic
DNA from a TPO-Cre mouse was PCR amplified using one
primer from chromosome 9 (primer 9.1) and one primer from
the transgene (TG1). The PCR product was subjected to
Sanger sequencing, confirming the 5¢ transgene integration
site (Fig. 3).
The transgene 3¢ insertion site was then identified in the
following manner. The sequencing library was subjected to
PCR using a primer directed at chromosome 9 downstream
from the transgene 5¢ integration site (primer 9.2; Fig. 1) with
a shortened version of LP2 denoted LP2a (shortened to create
a more optimal primer pair). Similar to the approach to
FIG. 2. Agarose gel electrophoresis of PCR products ob-
tained from nested PCR of sequencing library DNA. A first
round of PCR of the sequencing library DNA (not shown)
was performed using as one primer sequences from the ol-
igonucleotide adapter used for library construction (LP2),
and the second primer was directed at transgene sequences
near the 5¢ end of the transgene (TG1). The PCR product
was diluted 1000-fold, and 1 lL was used in a second round
of PCR with the same library adapter primer (LP2) plus a
transgene-specific primer that is nested relative to the round
1 PCR primer (TG2). This PCR yielded a smear of DNA
*100–300 bp. As a specificity control, TG2 was replaced by
TG3, which is directed at transgene sequences external to
the first round PCR product.
FIG. 3. Junction of chromosome 9 and the TPO-Cre transgene at the sequence level. Schematic shows the sequence of
chromosome 9 top strand whereas the transgene is inserted in the opposite orientation.
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identify the 5¢ insertion site, this PCR product was subjected
to a second round of PCR using a chromosome 9 primer (9.3)
that is nested relative to primer 9.2 with another shortened
version of LP2, denoted LP2b. The PCR product was sub-
jected to Sanger sequencing using primer 9.3, which identi-
fied the 3¢ transgene insertion site (Fig. 3). Note that
transgene integration resulted in deletion of chromosome
9 bp 12,372,317–12,372,323.
Development of a qualitative PCR assay to distinguish
hemizygous from homozygous TPO-Cre mice
To maximize efficiency, the authors’ laboratory uses ho-
mozygous TPO-Cre mice in breeding schemes, as noted
above. However, it is difficult to distinguish homozygous
from hemizygous TPO-Cre mice by quantitative real-time
PCR, since the expected difference in Ct values is only one
cycle. The genomic insertion site information was therefore
used to develop a qualitative PCR assay that can distinguish
wild type, hemizygous, and homozygous TPO-Cre mice.
This PCR utilizes chromosome 9 primers 9.1 and 9.4, which
flank the transgene, and one transgene primer (TG1; Fig. 4A).
This PCR yields a 379 bp product for the wild type allele
and a 332 bp product for the transgenic allele. Agarose gel
electrophoresis of the PCR products reliably distinguishes
wild type, hemizygous, and homozygous TPO-Cre mice
(Fig. 4B).
Discussion
A simple, efficient method has been developed to deter-
mine the insertion site of transgenes in transgenic mice, and
this has been applied to identify the insertion site of the TPO-
Cre transgene that is widely used to achieve thyroid-specific
expression of Cre. The insertion site was found to be between
bp 12,372,316 and 12,372,324 on mouse chromosome 9, with
the nearest characterized genes being Cntn5 and Jrkl, *1.5
and 0.9 Mbp from the transgene. Given these large distances,
it is very unlikely that the transgene will affect Cntn5 or Jrkl
gene expression. Cntn5 encodes a neuronal membrane pro-
tein that functions as a cell adhesion molecule, and the
function of the protein encoded by Jrkl is not known. There
are no known associations between these proteins and thyroid
biology. An advantage of this method is that PCR enrichment
of the sequencing library for transgene-containing sequences
allows for relatively shallow sequencing, thus decreasing the
cost and simplifying the data analysis. There are multiple
advantages to knowing a transgene insertion site. For ex-
ample, the transgene could potentially disrupt the expression
of nearby genes, or nearby sequences could influence the
expression of the transgene. In the present case, the authors
wished to develop a robust, qualitative assay to distinguish
hemizygous from homozygous TPO-Cre mice, and knowl-
edge of the transgene insertion site made it easy to establish
such an assay that can be run using conventional PCR.
A potential weakness of this method is that the 5¢ and 3¢
ends of the transgene are not always what one would predict
based upon the construct used to create the mice. The reason
for this is that the transgenic DNA usually concatemerizes
such that multiple head to tail copies are present within the
insertion site. The first or last copy of the transgene may not
be complete, and in fact, for TPO-Cre, it was found that the 3¢
most copy of the transgenic insert is partial and terminates in
the middle of the TPO promoter. This is a potential limitation
because to PCR-enrich the sequencing library one must use
nested primers that are near either the 5¢ or 3¢ end of the
inserted transgene. However, this is a minor issue because
only one of the two ends of the transgene has to be enriched,
and several different primers can be tried. In addition, any
PCR-based strategy, including the present one, may be dif-
ficult to apply if the transgene is flanked by sequences with
repetitive elements or has a high GC content resulting in poor
PCR performance.
Classical methods to determine transgene insertion sites
have utilized chromosome walking. A number of PCR-
based methods are available for chromosome walking, such
as inverse PCR (4), ligation-mediated PCR (5,6), and
specific-primer PCR (7,8), which identify transgene flank-
ing sequences. However, these methods are inefficient, can
generate nonspecific amplification products, and have other
deficiences that make them difficult to apply (9). Other re-
searchers have used a combination of microarray hybrid
capture and next-generation sequencing to identify transgene
insertion sites (10). This method, however, requires designing
a custom microarray for targeted sequence capture and en-
richment. Shallow coverage whole genome sequencing has
also been carried out in combination with searching for tandem
duplications to help identify the transgenic insert, although this
method would not be feasible for transgenic inserts without
tandem repeats (11). The present method of combining PCR
FIG. 4. Qualitative PCR genotyping of wild type, hemi-
zygous, and homozygous TPO-Cre mouse DNA. (A) The
PCR reaction utilizes two primers in chromosome 9 and one
primer in the TPO-Cre transgene. PCR results in a 332 bp
product for the transgenic allele and a 379 bp product for the
wild type allele. (B) Agarose gel electrophoresis of the PCR
products from tail DNA of three wild type mice (WT), three
hemizygous TPO-Cre mice (Cre/+), and three homozygous
TPO-Cre mice (Cre/Cre).
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with next-generation sequencing helps to enrich the transgenic
insertion sites and thus is cost-effective and efficient. The
predicted genomic integration sites allow for designing a fast
and convenient PCR method to determine and distinguish the
zygosity status of the transgenic mice studied.
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